Marrow visualization on renal scintigraphy: An often-overlooked finding in azotemic patients

Anton Shapoval, Murthy Chamarthy, M. Donald Blaufox, Leonard M. Freeman

Research output: Contribution to journalArticle

Abstract

Delayed perfusion and enhanced hepatobiliary uptake are recognized findings on 99mTc-mercaptoacetyltriglycine (99mTc-MAG3) scintigraphy in patients with renal insufficiency. Less well appreciated is the finding of bone marrow visualization. This study was performed to determine the frequency of this sign and to try to determine its association with laboratory parameters. Methods: We retrospectively studied medical records and the results of renal scans performed on 170 patients from June to December 2009 at the Montefiore Medical Center. Among them we identified 167 patients who fulfilled our inclusion criteria for participation in this study. Prominent individual vertebrae and sacroiliac joints were categorized as bone marrow visualization. A lack of radiotracer activity in individual vertebrae or in the sacroiliac joints was categorized as bone marrow nonvisualization. The studies were interpreted by 2 nuclear medicine physicians who were unaware of the laboratory and clinical data. Results: The 167 patients fulfilling our inclusion criteria were divided into 2 groups: group 1 (n = 20), with visualization, and group 2 (n = 147), without visualization. The mean creatinine level in group 1 was higher than that in group 2 (3.2 vs. 1.1, P = 0.001). There was no difference in mean hematocrit and hemoglobin between the 2 groups. None of the patients with a creatinine level less than 1.5 mg/dL had bone marrow visualization, whereas bone marrow was visualized in 44% of patients with a creatinine level greater than 1.5 mg/dL. There was no definite correlation between the intensity of marrow activity and the level of creatinine. Conclusion: Bone marrow often may be visualized on early images of 99mTc-MAG3 renal scans of azotemic patients. The etiology needs further clarification. Enhanced marrow perfusion, an increased blood concentration of 99mTc-MAG3, and marrow hyperplasia secondary to associated anemia or hemolysis are possible causes.

Original languageEnglish (US)
Pages (from-to)901-904
Number of pages4
JournalJournal of Nuclear Medicine
Volume52
Issue number6
DOIs
StatePublished - Jun 1 2011

Fingerprint

Radionuclide Imaging
Bone Marrow
Technetium Tc 99m Mertiatide
Kidney
Creatinine
Sacroiliac Joint
Spine
Perfusion
Nuclear Medicine
Hemolysis
Hematocrit
Hyperplasia
Medical Records
Renal Insufficiency
Anemia
Hemoglobins
Physicians

Keywords

  • Tc
  • Bone
  • Bone marrow visualization
  • Genitourinary
  • MAG3 renal scan
  • Renal scintigraphy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Marrow visualization on renal scintigraphy : An often-overlooked finding in azotemic patients. / Shapoval, Anton; Chamarthy, Murthy; Blaufox, M. Donald; Freeman, Leonard M.

In: Journal of Nuclear Medicine, Vol. 52, No. 6, 01.06.2011, p. 901-904.

Research output: Contribution to journalArticle

Shapoval, Anton ; Chamarthy, Murthy ; Blaufox, M. Donald ; Freeman, Leonard M. / Marrow visualization on renal scintigraphy : An often-overlooked finding in azotemic patients. In: Journal of Nuclear Medicine. 2011 ; Vol. 52, No. 6. pp. 901-904.
@article{8b164063a44c4a868b75de063b93e651,
title = "Marrow visualization on renal scintigraphy: An often-overlooked finding in azotemic patients",
abstract = "Delayed perfusion and enhanced hepatobiliary uptake are recognized findings on 99mTc-mercaptoacetyltriglycine (99mTc-MAG3) scintigraphy in patients with renal insufficiency. Less well appreciated is the finding of bone marrow visualization. This study was performed to determine the frequency of this sign and to try to determine its association with laboratory parameters. Methods: We retrospectively studied medical records and the results of renal scans performed on 170 patients from June to December 2009 at the Montefiore Medical Center. Among them we identified 167 patients who fulfilled our inclusion criteria for participation in this study. Prominent individual vertebrae and sacroiliac joints were categorized as bone marrow visualization. A lack of radiotracer activity in individual vertebrae or in the sacroiliac joints was categorized as bone marrow nonvisualization. The studies were interpreted by 2 nuclear medicine physicians who were unaware of the laboratory and clinical data. Results: The 167 patients fulfilling our inclusion criteria were divided into 2 groups: group 1 (n = 20), with visualization, and group 2 (n = 147), without visualization. The mean creatinine level in group 1 was higher than that in group 2 (3.2 vs. 1.1, P = 0.001). There was no difference in mean hematocrit and hemoglobin between the 2 groups. None of the patients with a creatinine level less than 1.5 mg/dL had bone marrow visualization, whereas bone marrow was visualized in 44{\%} of patients with a creatinine level greater than 1.5 mg/dL. There was no definite correlation between the intensity of marrow activity and the level of creatinine. Conclusion: Bone marrow often may be visualized on early images of 99mTc-MAG3 renal scans of azotemic patients. The etiology needs further clarification. Enhanced marrow perfusion, an increased blood concentration of 99mTc-MAG3, and marrow hyperplasia secondary to associated anemia or hemolysis are possible causes.",
keywords = "Tc, Bone, Bone marrow visualization, Genitourinary, MAG3 renal scan, Renal scintigraphy",
author = "Anton Shapoval and Murthy Chamarthy and Blaufox, {M. Donald} and Freeman, {Leonard M.}",
year = "2011",
month = "6",
day = "1",
doi = "10.2967/jnumed.110.085555",
language = "English (US)",
volume = "52",
pages = "901--904",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "6",

}

TY - JOUR

T1 - Marrow visualization on renal scintigraphy

T2 - An often-overlooked finding in azotemic patients

AU - Shapoval, Anton

AU - Chamarthy, Murthy

AU - Blaufox, M. Donald

AU - Freeman, Leonard M.

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Delayed perfusion and enhanced hepatobiliary uptake are recognized findings on 99mTc-mercaptoacetyltriglycine (99mTc-MAG3) scintigraphy in patients with renal insufficiency. Less well appreciated is the finding of bone marrow visualization. This study was performed to determine the frequency of this sign and to try to determine its association with laboratory parameters. Methods: We retrospectively studied medical records and the results of renal scans performed on 170 patients from June to December 2009 at the Montefiore Medical Center. Among them we identified 167 patients who fulfilled our inclusion criteria for participation in this study. Prominent individual vertebrae and sacroiliac joints were categorized as bone marrow visualization. A lack of radiotracer activity in individual vertebrae or in the sacroiliac joints was categorized as bone marrow nonvisualization. The studies were interpreted by 2 nuclear medicine physicians who were unaware of the laboratory and clinical data. Results: The 167 patients fulfilling our inclusion criteria were divided into 2 groups: group 1 (n = 20), with visualization, and group 2 (n = 147), without visualization. The mean creatinine level in group 1 was higher than that in group 2 (3.2 vs. 1.1, P = 0.001). There was no difference in mean hematocrit and hemoglobin between the 2 groups. None of the patients with a creatinine level less than 1.5 mg/dL had bone marrow visualization, whereas bone marrow was visualized in 44% of patients with a creatinine level greater than 1.5 mg/dL. There was no definite correlation between the intensity of marrow activity and the level of creatinine. Conclusion: Bone marrow often may be visualized on early images of 99mTc-MAG3 renal scans of azotemic patients. The etiology needs further clarification. Enhanced marrow perfusion, an increased blood concentration of 99mTc-MAG3, and marrow hyperplasia secondary to associated anemia or hemolysis are possible causes.

AB - Delayed perfusion and enhanced hepatobiliary uptake are recognized findings on 99mTc-mercaptoacetyltriglycine (99mTc-MAG3) scintigraphy in patients with renal insufficiency. Less well appreciated is the finding of bone marrow visualization. This study was performed to determine the frequency of this sign and to try to determine its association with laboratory parameters. Methods: We retrospectively studied medical records and the results of renal scans performed on 170 patients from June to December 2009 at the Montefiore Medical Center. Among them we identified 167 patients who fulfilled our inclusion criteria for participation in this study. Prominent individual vertebrae and sacroiliac joints were categorized as bone marrow visualization. A lack of radiotracer activity in individual vertebrae or in the sacroiliac joints was categorized as bone marrow nonvisualization. The studies were interpreted by 2 nuclear medicine physicians who were unaware of the laboratory and clinical data. Results: The 167 patients fulfilling our inclusion criteria were divided into 2 groups: group 1 (n = 20), with visualization, and group 2 (n = 147), without visualization. The mean creatinine level in group 1 was higher than that in group 2 (3.2 vs. 1.1, P = 0.001). There was no difference in mean hematocrit and hemoglobin between the 2 groups. None of the patients with a creatinine level less than 1.5 mg/dL had bone marrow visualization, whereas bone marrow was visualized in 44% of patients with a creatinine level greater than 1.5 mg/dL. There was no definite correlation between the intensity of marrow activity and the level of creatinine. Conclusion: Bone marrow often may be visualized on early images of 99mTc-MAG3 renal scans of azotemic patients. The etiology needs further clarification. Enhanced marrow perfusion, an increased blood concentration of 99mTc-MAG3, and marrow hyperplasia secondary to associated anemia or hemolysis are possible causes.

KW - Tc

KW - Bone

KW - Bone marrow visualization

KW - Genitourinary

KW - MAG3 renal scan

KW - Renal scintigraphy

UR - http://www.scopus.com/inward/record.url?scp=79958102943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958102943&partnerID=8YFLogxK

U2 - 10.2967/jnumed.110.085555

DO - 10.2967/jnumed.110.085555

M3 - Article

C2 - 21571806

AN - SCOPUS:79958102943

VL - 52

SP - 901

EP - 904

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 6

ER -